Evidence map›Paper›PMID 34815726›Full record

ArticleRisk management and healthcare policy2021

China's COVID-19 Vaccination Strategy and Its Impact on the Global Pandemic.

Zhigang Meng, Shoujin Shan, Ruilian Zhang

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Achilles' heel: elderly COVID-19 vaccination policy in China.Health research policy and systems · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Risk Perception and Acceptability of the COVID-19 Vaccine in Nigeria.Turkish journal of pharmaceutical sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhigang MengSchool of Marxism, Hohai University, Nanjing, 211100, People's Republic of China.
Shoujin ShanSchool of Marxism, Hohai University, Nanjing, 211100, People's Republic of China.
Ruilian ZhangSustainable Minerals Institute, The University of Queensland, Brisbane, Australia.ORCID 0000-0001-5064-1226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public health crises are challenging for governments and health systems. Vaccines are a key solution to viruses, and immunization has always played a critical role during public health crises in the past century. In the context of coronavirus disease 2019 (COVID-19), we explore China's vaccination strategies and challenges. Accordingly, we identify the causes of the high vaccination rate in China, including technical and nontechnical factors. Considering the impact of China's high vaccination rate on the global pandemic, we argue that it has strengthened China's opportunities and capabilities to participate in global development, enhanced the equity of vaccines and given the world community more choices.

Indexed as

COVID-19equitypublic health crisisvaccines

Identifiers

PMID34815726
PMCPMC8604646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.